The stock market performance of Black Diamond Therapeutics Inc has been very steady. Over the last year, the company’s stock hit its highest at $7.66 on 05/06/24, while the lowest price during the same time frame was $1.62, recorded on 11/10/23.
52-week price history of BDTX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Black Diamond Therapeutics Inc’s current trading price is -34.60% away from its 52-week high, while its distance from the 52-week low is 209.26%. The stock’s price range for this period has remained between $1.62 and $7.66. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.85 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.79 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Black Diamond Therapeutics Inc (BDTX) has experienced a quarterly decline of -6.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 281.81M and boasts a workforce of 54 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.12, with a change in price of +0.87. Similarly, Black Diamond Therapeutics Inc recorded 718,061 in trading volume during the last 100 days, posting a change of +21.01%.
BDTX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BDTX stands at 0.24. Similarly, the long-term debt-to-equity ratio is also 0.20.
BDTX Stock Stochastic Average
As of today, the raw stochastic average of Black Diamond Therapeutics Inc over the past 50 days is 24.50%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 38.05%. Additionally, the Stochastic %K and %D values for the company were 20.65% and 15.38%, respectively, over the past 20 days.
BDTX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 78.29% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 83.52%. Over the past 30 days, the price of BDTX has fallen by 7.74%. And in the last five days, it has surged by 6.60%.
